CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $14,000 | +16.7% | 2,870 | +195.6% | 0.00% | -100.0% |
| Q4 2020 | $12,000 | -14.3% | 971 | -31.4% | 0.00% | 0.0% |
| Q3 2020 | $14,000 | +27.3% | 1,416 | +26.7% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | – | 1,118 | +4558.3% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 24 | -98.4% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | +800.0% | 1,479 | +1197.4% | 0.01% | +600.0% |
| Q3 2017 | $2,000 | +100.0% | 114 | +14.0% | 0.00% | 0.0% |
| Q3 2016 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |